Prevencio, Inc.
PrivateLast Round
Accelerator
May 29, 2024
Total Funding Raised
$24.35M
Company Overview
Prevencio, Inc. operates in Healthcare & Life Sciences and is based in Kirkland, Washington. Its latest recorded funding round was an Accelerator round in May 2024.
Prevencio, Inc. is a biotechnology company that develops AI-driven, multi-protein blood tests for the diagnosis and risk assessment of cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Prevencio, Inc. Comparables
Compare Prevencio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prolocor | 79% | |
| Zora Biosciences | 78% | |
| numares Health | 77% |
For institutional investors. Book with your work email.
Prevencio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 29, 2024 | ||||
| Series B Extension | Mar 1, 2022 | ||||
| Accelerator | Oct 17, 2019 | ||||
| Debt | Aug 19, 2019 | ||||
| Series B | Jun 30, 2016 | ||||
Series B | Mar 23, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Prevencio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| Bayer G4A | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 178% to 6.3K.
- Jan 20, 2026
Monthly visitors increased 46% MoM, reaching 1.4K.
For institutional investors. Book with your work email.
Prevencio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Prevencio, Inc.'s valuation, stock price, and market status.
Is Prevencio, Inc. a public or private company?
Prevencio, Inc. is a private company.
What is the current stock price of Prevencio, Inc.?
Prevencio, Inc. is a private company, so its shares have no public market price. Caplight tracks Prevencio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Prevencio, Inc. worth (valuation)?
Valuation information for Prevencio, Inc. is not publicly available.
Can I buy Prevencio, Inc. stock?
Prevencio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Prevencio, Inc.'s last funding round?
Prevencio, Inc.'s most recent funding round was Accelerator on May 29, 2024.
Who are the main investors in Prevencio, Inc.?
Key investors in Prevencio, Inc. include MedTech Innovator, Bayer G4A.
Will Prevencio, Inc. IPO soon?
No public IPO plans have been announced for Prevencio, Inc..
How can I track Prevencio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Prevencio, Inc.'s shares on secondary markets.